Search

for
Search:

Glossary RU58841

non-steroidal anti-androgen researched for treating androgenic alopecia

RU58841 is a non-steroidal anti-androgen that is often researched for its potential to treat androgenic alopecia (pattern hair loss). It works by binding to androgen receptors in the scalp, thereby preventing dihydrotestosterone (DHT) from attaching to these receptors and causing hair follicle miniaturization.

Related Terms

Learn

2 / 801 results

learn RU58841

a potent but unapproved and potentially problematic topical anti-androgen

Is RU58841 magic or a scam? Does it really stop baldness? RU58841 is an unapproved research chemical: the published evidence is animal and lab work from the 1990s, there has never been a controlled human trial for hair loss, and nothing sold online is quality-controlled — so its effect and its long-term safety in people are both unknown.
RU58841: What's the difference between minoxidil and finasteride? Minoxidil stimulates hair growth, while finasteride reduces DHT levels to prevent hair loss.
Will I lose my hair if I stop using RU58841? (Spoiler: I might.) There is no published human trial of stopping RU58841; community members commonly report shedding within weeks to months, and androgen biology suggests miniaturization would resume once the topical anti-androgen is withdrawn.
All 5 questions on RU58841 →

learn DECAPEPTIDE-28

View more "RU58841" in learn →

Community Join

5 / 1000+ results

community Is RU58841 making a comeback? Is it worth it?

5 upvotes 1 week ago

RU58841 is being reconsidered as a hair loss treatment, with some users reporting early positive signs, though concerns about potential heart issues exist. Alternatives like KX826 and traditional treatments like dutasteride and minoxidil are also discussed.

community New human study (Aug 2026) directly tested whether RU58841 stays local - it doesn't

8 upvotes 2 weeks ago

RU58841 is absorbed systemically in humans, contradicting claims it stays local, but no harm is proven. Alternatives like CB-03-01 or KX-826, especially with finasteride, are suggested for safety.

community Latest study on RU58841 done 19. August 2026.

25 upvotes 3 weeks ago

RU58841 can be absorbed systemically after topical application, but the study did not find immediate hormonal disruption. The study highlights the need for more research on long-term safety and effects of RU58841, as well as the importance of quality control in products from the grey market.

community How many have experimented with ru58841 and topical GHK-CU?

9 upvotes 1 month ago

RU58841 and topical GHK-CU are used together for hair loss, with RU58841 reducing shedding and GHK-CU improving scalp health. Users report noticeable hair growth and improved hair quality within weeks, especially when used consistently.

community RU58841 is a scam until proven otherwise

15 upvotes 1 month ago

RU58841 is considered ineffective as a standalone treatment for hair loss, with users often combining it with finasteride and minoxidil for potential benefits. Many users report mixed results and concerns about side effects, leading to skepticism about its efficacy.

View more "RU58841" in community →

Research

5 / 1000+ results

research RU 58841, a new specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism

49 citations , January 1994 in “The Journal of Steroid Biochemistry and Molecular Biology”

This study found that the topically applied non-steroidal antiandrogen RU 58841 may reduce androgen-dependent skin conditions in a hamster model with minimal systemic effects.

research RU 58841-myristate–prodrug development for topical treatment of acne and androgenetic alopecia.

26 citations , January 2005 in “PubMed”

This study reports that RU 58841-myristate, a new antiandrogen prodrug formulated with solid lipid nanoparticles, shows potential for targeting hair follicles in preclinical laboratory settings.

A Controlled Study of the Effects of RU58841, a Non-Steroidal Antiandrogen, on Human Hair Production by Balding Scalp Grafts Maintained on Testosterone-Conditioned Nude Mice

research A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice

10 citations , November 1997 in “British Journal of Dermatology”

This study found that the non-steroidal antiandrogen RU58841 increased hair growth rates and promoted hair cycle initiation in balding human scalp grafts on testosterone-conditioned nude mice, indicating a positive effect on hair growth.

research Alternative synthesis of the anti-baldness compound RU58841

4 citations , January 2014 in “RSC Advances”

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

research Dose-dependent and long term effects of RU58841 (androgen receptor blocker) on hair growth in the bald stumptailed Macaque.

1 citations , January 1997 in “Journal of Investigative Dermatology”

In this study using a macaque model, RU58841 at a 5% concentration significantly increased hair density, thickness, and length in the frontal bald scalp over six months.

View more "RU58841" in research →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →